Advertisement

Acta Neurochirurgica

, Volume 73, Issue 1–2, pp 13–23 | Cite as

Single agent therapy of interferon for brain tumours: Correlation between natural killer activity and clinical course

  • Sh. Otsuka
  • H. Handa
  • J. Yamashita
  • K. Suda
  • J. Takeuchi
Article

Summary

The anti-tumour effect of mouse interferon (IFN) on an intracranially transplanted 203-glioma in C 57 BL mice and the natural killer (NK) activity of spleen cells were studied. As a clinical trial, five patients with glioblastomas were treated with human fibroblast IFN and the anti-tumour effect of IFN and the NK activity of peripheral blood lymphocytes were also studied. The NK activity increased after the beginning of IFN therapy but there was no remarkable antitumour effect of IFN in both mouse and human studies. There was no marked correlation between the increased NK activity and the anti-tumour effect of IFN in this study.

Keywords

Brain tumour interferon natural killer 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Blomgren, H., Cantell, K., Johansson, B., Lagergren, C., Ringborg, U., Strander, H., Interferon therapy in Hodgkin's disease. Acta Med. Scand.199 (1976), 527–532.PubMedGoogle Scholar
  2. 2.
    Boëthius, J., Blomgren, H., Collins, V. P., Greitz, T., Strander, H., The Effect of Systemic Human Interferon-Alpha Administration to Patients with Glioblastoma Multiforme. Acta Neurochir. (Wien)68 (1983), 239–251.Google Scholar
  3. 3.
    Ezaki, K., Okabe, K., Inagaki, J., Horikoshi, N., Inoue, K., Aiba, K., Domyo, M., Nagata, T., Ogawa, M., Clinical study of human fibroblast interferon. Gan To Kagakuryoho.9 (1982), 31–37.Google Scholar
  4. 4.
    Ezaki, K., Okabe, K., Domyo, M., Abe, K., Ogawa, M., Immunological studies in patients with malignant diseases under treatment of human fibroblast interferon. Gan To Kagakuryoho.9 (1982), 238–243.Google Scholar
  5. 5.
    Gresser, I., Anti tumor effects of interferon. Adv. Cancer Res.16 (1972), 97–140.PubMedGoogle Scholar
  6. 6.
    Gresser, I., Maury, C., Tovey, M., Interferon and murine leukemia. VII. Therapeutic effect of interferon preparations after diagnosis of lymphoma in AKR mice. Int. J. Cancer.17 (1976), 647–651.PubMedGoogle Scholar
  7. 7.
    Gutterman, J. U., Blumenschein, G. R., Alexanian, R., Yap, H. Y., Buzdar, A. U., Cabanillas, F., Hortobagyi, G. N., Hersh, E. M., Rasmussen, S. L., Harmon, M., Kramer, M., Pestka, S., Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphoma. Ann. Int. Med.93 (1980), 399–406.PubMedGoogle Scholar
  8. 8.
    Isaacs, A., Lindenmann, J., Virus intereference. I. The interferon. Pro. Royal Soc. London.147 (1957), 258–267.Google Scholar
  9. 9.
    Kasai, M., Leclerc, J. C., McVay-Boudreau, L., Shen, F. W., Cantor, H., Direct evidence that natural killer cells in nonimmune spleen cell populations prevent tumor growth in vivo. J. exp. Med.149 (1979), 1260–1264.PubMedGoogle Scholar
  10. 10.
    Lindahl, P., Leary, P., Gresser, I., Enhancement by Interferon of the specific cytotoxicity of sensitized lymphocytes. Pro. Natl. Acad. Sci. U.S.A.69 (1972), 721–725.Google Scholar
  11. 11.
    Nagai, M., Arai, T., Interferon therapy for malignant brain tumors — present and future. Neurol. Surg.10 (1982), 463–476.Google Scholar
  12. 12.
    Otsuka, S., Suda, K., Yamashita, J., Takeuchi, J., Handa, H., Changes of natural killer activity following local60Co irradiation in intracranial tumorbearing mice. Brain and Nerve34 (1982), 393–398.PubMedGoogle Scholar
  13. 13.
    Otsuka, S., Suda, K., Yamashita, J., Takeuchi, J., Handa, H., Natural killer activity of peripheral blood lymphocytes in patients with brain tumors. Neurol. Surg.10 (1982), 1291–1297.Google Scholar
  14. 14.
    Schuluz, R. M., Papamatheakis, J. D., Chirigos, M. A., Interferon: An inducer of macrophage activation by polyanions. Science197 (1977), 674–676.PubMedGoogle Scholar
  15. 15.
    Senik, A., Gresser, I., Maury, C., Gidlund, M., Orn, A., Wigzell, H., Enhancement by interferon of natural killer cell activity in mice. Cell. Immunol.44 (1979), 186–200.PubMedGoogle Scholar
  16. 16.
    Strander, H., Cantell, K., Jakobsson, P. A., Nilsonne, U., Söderberg, G., Exogenus interferon therapy of osteogenic sarcoma. Acta Orthop. Scand.45 (1974), 958–959.Google Scholar
  17. 17.
    Strander, H., Einhorn, S., Effect of human leukocyte interferon on the growth of human osteosarcoma cells in tissue culture. Int. J. Cancer.19 (1977), 468–473.PubMedGoogle Scholar
  18. 18.
    Takasugi, M., Mickey, M. R., Terasaki, P. I., Reactivity of lymphocytes from normal persons on cultured tumor cells. Cancer Res.33 (1973), 2898–2902.PubMedGoogle Scholar
  19. 19.
    Tozawa, M., Kidowaki, T., Tanaka, T., Sawada, T., Kusunoki, T., Therapeutic effect of interferon on C 1,300 mouse neuroblastoma. Igakuno Ayumi.118 (1981), 279–281.Google Scholar
  20. 20.
    Trinchieri, G., Santoli, D., Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis. J. exp. Med.147 (1978), 1314–1333.PubMedGoogle Scholar
  21. 21.
    Ueda, S., Hirakawa, K., Suzuki, K., Nakagawa, Y., Ibayashi, N., Kishida, T., Interferon therapy of brain tumor patients. Neurol. Surg.10 (1982), 149–154.Google Scholar

Copyright information

© Springer-Verlag 1984

Authors and Affiliations

  • Sh. Otsuka
    • 1
  • H. Handa
    • 1
  • J. Yamashita
    • 1
  • K. Suda
    • 1
    • 2
  • J. Takeuchi
    • 1
  1. 1.Department of NeurosurgeryKyoto University Medical SchoolJapan
  2. 2.Department of NeurosurgeryShiga Medical SchoolJapan

Personalised recommendations